Rao et al. [11] found in a JAK2 mutant MPN mouse model that enhanced JAK2 mutation disrupted the metabolic homeostasis of MPN cells, resulting in systemic metabolic changes in vivo, including elevated levels of glycolysis, oxidative phosphorylation, adipose tissue atrophy, and early death. Here, JAK2 is linked to myeloproliferative neoplasm.